Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells

BACKGROUND: Thalidomide is an immunomodulatory agent, which arrests angiogenesis. The mechanism of anti-angiogenic activity of thalidomide is not fully understood. As nitric oxide is involved in angiogenesis, we speculate a cross-talk between thalidomide and nitric oxide signaling pathway to define...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamilarasan, KP, Kolluru, Gopi Krishna, Rajaram, Megha, Indhumathy, M, Saranya, R, Chatterjee, Suvro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456963/
https://www.ncbi.nlm.nih.gov/pubmed/16584574
http://dx.doi.org/10.1186/1471-2121-7-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456963/
https://www.ncbi.nlm.nih.gov/pubmed/16584574
http://dx.doi.org/10.1186/1471-2121-7-17

Ejemplares similares